The American Heart Association's recent scientific statement on cardiac critical care: implications for pediatric

Daniel J Penny1, Lara S Shekerdemian

  • 1Division of Cardiology, Texas Children's Hospital, Houston, TX 77030, USA. djpenny@texaschildrens.org

Congenital Heart Disease
|January 3, 2013
PubMed

Insights

The American Heart Association developed a critical care roadmap for cardiovascular disease. This framework offers valuable insights for improving pediatric cardiac critical care.

Area of Science:

  • Cardiology
  • Critical Care Medicine
  • Pediatric Cardiology

Background:

  • The American Heart Association (AHA) established a writing group comprising multiple councils.
  • This group formulated a roadmap to address evolving patient needs in cardiovascular critical care.
  • The roadmap primarily targets adult critical cardiovascular disease but has implications for pediatric care.

Observation:

  • The authors examined the AHA's roadmap statement.
  • They applied the roadmap's framework to the field of pediatric cardiac critical care.
  • This analysis focuses on the adaptation of adult-centric critical care strategies for pediatric populations.

Findings:

  • The AHA roadmap provides a structured approach to critical care for cardiovascular disease.
  • Key principles from the roadmap are applicable to the unique challenges in pediatric cardiac intensive care.
  • The framework aids in organizing and advancing care for critically ill children with heart conditions.

Implications:

  • The application of the AHA roadmap can enhance the quality of care for pediatric cardiac patients.
  • This approach may guide the development of specialized guidelines for pediatric cardiac critical care.
  • Implementing the roadmap's principles can lead to improved outcomes for critically ill children with cardiovascular disease.

Related Concept Videos

Cardiopulmonary Resuscitation III: AED Use01:23

Cardiopulmonary Resuscitation III: AED Use

Introduction to AEDAn Automated External Defibrillator (AED) is a portable medical device that analyzes the heart's rhythm and, if necessary, delivers an electrical shock to help the heart re-establish an effective rhythm during sudden cardiac arrest (SCA). SCA occurs when the heart suddenly and unexpectedly stops beating, leading to a loss of blood flow to the brain and other vital organs. In such emergencies, time is of the essence, and using an AED, combined with Cardiopulmonary...
Cardiopulmonary Resuscitation IV: Pharmacological Management01:25

Cardiopulmonary Resuscitation IV: Pharmacological Management

Pharmacologic intervention is crucial in treating cardiac arrest patients during ACLS or Advanced Cardiovascular Life Support. The ACLS algorithms guide the administration of specific drugs based on the patient's cardiac arrest rhythm, which includes pulseless ventricular tachycardia (VT), ventricular fibrillation (VF), asystole, and pulseless electrical activity (PEA).EpinephrineIndication: Epinephrine is the first-line drug for all cardiac arrest rhythms.Mechanism of Action: Epinephrine...
Cardiopulmonary Resuscitation I: Adult01:21

Cardiopulmonary Resuscitation I: Adult

Cardiopulmonary resuscitation, or CPR, is a life-saving emergency procedure performed when a person's heart has stopped beating or they are no longer breathing. The foundation of CPR is Basic Life Support (BLS), which focuses on the early recognition of cardiac arrest, the immediate start of high-quality chest compressions, and the timely use of an automated external defibrillator (AED).Assessing Responsiveness and Checking the Carotid PulseWhen approaching an unresponsive person, first ensure...
Acute Coronary Syndrome IV: Interprofessional Care01:28

Acute Coronary Syndrome IV: Interprofessional Care

IntroductionThe management of Acute Coronary Syndrome (ACS) aims to minimize myocardial damage, preserve myocardial function, and prevent complications.Initial ManagementInpatient management involves continuous cardiac monitoring, preferably in an ICU, focusing on blood pressure, serum sodium, potassium, and creatinine levels, and urine output. Ongoing pharmacologic management is crucial for stabilizing the patient.Supplemental Oxygen: Administer supplemental oxygen if oxygen saturation is...
Heart Failure VI: Adjunct Therapies01:22

Heart Failure VI: Adjunct Therapies

Additional therapies for treating patients with heart failure (HF) may include procedural interventions, supplemental oxygen, the management of sleep disorders, and nutritional therapy.Procedural InterventionsImplantable Cardioverter-Defibrillator: For patients at risk of life-threatening arrhythmias due to severe left ventricular dysfunction, an Implantable Cardioverter-Defibrillator (ICD) can detect and terminate these arrhythmias, preventing sudden cardiac death and improving survival rates.
Cardiomyopathy III: Hypertrophic Cardiomyopathy01:29

Cardiomyopathy III: Hypertrophic Cardiomyopathy

Hypertrophic cardiomyopathy, or HCM, is an autosomal dominant genetic disorder characterized by asymmetric left ventricular hypertrophy without ventricular dilation. It is more common in men and is typically diagnosed in young, athletic adults.EtiologyHCM is primarily genetic and is caused by mutations in genes encoding sarcomeric proteins. Researchers have identified over 1400 mutations across at least 11 different genes. Among these, the most frequently occurring mutations are found in the...